Yentl syndrome

From WikiMD's WELLNESSPEDIA

Yentl Syndrome is a term coined in the medical field to describe a bias in the treatment and diagnosis of heart disease in women. The term was first introduced by Dr. Bernadine Healy in 1991, referencing the movie Yentl where a woman had to disguise herself as a man to receive the same treatment as her male counterparts.

Overview[edit]

Yentl Syndrome is a phenomenon where women with heart disease are not diagnosed or treated as aggressively as men because their symptoms are often different and less recognizable. This can lead to a delay in treatment, which can result in more severe outcomes for women.

History[edit]

The term was first used by Dr. Bernadine Healy, the first woman to head the National Institutes of Health, in a 1991 article in the New England Journal of Medicine. She used the term to highlight the disparity in treatment between men and women when it comes to heart disease.

Symptoms and Diagnosis[edit]

Women with heart disease often present with different symptoms than men. While men often experience chest pain, women may experience symptoms such as fatigue, shortness of breath, and nausea. These symptoms are often overlooked or misdiagnosed, leading to a delay in treatment.

Treatment[edit]

Once diagnosed, women with heart disease are often not treated as aggressively as men. This can include less aggressive use of procedures such as angioplasty and bypass surgery. This disparity in treatment can lead to worse outcomes for women.

Impact[edit]

The impact of Yentl Syndrome is significant. It contributes to the higher mortality rates seen in women with heart disease compared to men. It also highlights the need for more research and education on the unique symptoms and treatment needs of women with heart disease.

See Also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.